Loading...
Freedom of Information (FOI) NHS Lothian | Our Organisation

Request and Response Register

NOTE: 100 recent requests are displayed below. Use search to find older requests.
Freedom of Information Request Reference: 12037
Date Received: 12/10/2026
Summary:
Has NHS Lothian published or updated any local treatment guidelines, pathways or protocols for the treatment of the interstitial lung diseases (ILD), idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF) since April 2023?
Date of Response: 20/10/2026
View Response: 12037.pdf
Freedom of Information Request Reference: 11992
Date Received: 02/10/2026
Summary:
We kindly request your transparency data, under the Freedom of Information Act 2000, for all transactions over £25,000 for the following period: March 2023 onwards.
Date of Response: 09/10/2026
View Response: 11992.pdf
Freedom of Information Request Reference: 11982
Date Received: 29/09/2026
Summary:
In each of the past 10 financial years and the current financial year (2015/16– 2026/27), broken down by both hospital and month. 1. How many patients waited over a) 15 minutes; b) 30 minutes; c) 45 minutes) d) one hour to be triaged? 2. What was the longest A&E triage time?
Date of Response: 12/10/2026
View Response: 11982.pdf
Freedom of Information Request Reference: 11973
Date Received: 28/09/2026
Summary:
Please provide information relating to acute mental health inpatient services provided by NHS Lothian for the period 1st January 2020 to 31st December 2025 Specifically, I would like to obtain: 1. The total number of discharges from acute mental health inpatient services during this period. 2. The number of patients who were readmitted to an acute mental health inpatient service within 30 days of discharge during the same period. 3. The percentage of discharges that resulted in a readmission within 30 days, calculated as: Number of readmissions within 30 days ÷ total number of discharges × 100 4. Where available, please provide the above figures broken down by calendar year (or financial year), rather than only as an aggregate for the whole requested period. 5. If the Board records this measure under a different terminology or definition (for example, a 30-day readmission rate), please provide the relevant recorded figure and the definition used.
Date of Response: 20/10/2026
View Response: 11973.pdf
Freedom of Information Request Reference: 11970
Date Received: 28/09/2026
Summary:
Under Freedom of Information, can you please provide a breakdown of the Health Board's Chief Executive's total expenses for the last three financial years and this year so far (up to Sep 1)? Can the breakdown include destination, accommodation, and travel (including taxis, trains, and flights by first, business, and economy class)
Date of Response: 16/10/2026
View Response: 11970.pdf
Freedom of Information Request Reference: 11969
Date Received: 25/09/2026
Summary:
Please provide the following information for each financial year from 2021/22 to 2025/26: 1. The number of patients discharged following a drug-related hospital stay who had another drug-related hospital stay within 30 days, and within 90 days, of discharge. 2. The number of patients discharged following an alcohol-related hospital stay who had another alcohol-related hospital stay within 30 days, and within 90 days, of discharge. 3. The number of patients who had three or more drug-related hospital stays during the financial year, and the total number of stays involving those patients. 4. The number of patients who had three or more alcohol-related hospital stays during the financial year, and the total number of stays involving those patients.
Date of Response: 21/10/2026
View Response: 11969.pdf
Freedom of Information Request Reference: 11968
Date Received: 25/09/2026
Summary:
1. What is the resident population size for NHS Lothian Health Board? 2. What is the ideal number of rheumatology consultants for the aforementioned population size? 3. How many WTE consultant rheumatologists do you currently employ in your rheumatology team/s? 4. How many WTE associate specialists do you currently employ in your rheumatology team/s? 5. How many WTE specialist rheumatology physiotherapists do you currently employ in your rheumatology team/s 6. How many WTE specialist rheumatology occupational therapists do you currently employ in your rheumatology team/s 7. How many WTE specialist rheumatology podiatrists do you currently employ in your rheumatology team/s 8. How many WTE pharmacists to you currently employ in your rheumatology team/s who are part of the rheumatology multidisciplinary team? 9. Do you employ any specialist talking therapy staff who are employed in your rheumatology multidisciplinary team? 10. How many WTE Specialist Nurses do you currently employ in your rheumatology team? 11. Proportion of work done on behalf of GPs (expressed as WTE consultant session/PA) e.g. prescribing/monitoring DMARDs, responding to queries from Teams appointed to support GPs (e.g. Pharmacists/ANPs/FCP) which would have been addressed by a GP in the practice etc. 12. Planned consultant retirements/partial retirements in the next 3 years for the rheumatology department 13. Planned consultant retirements/partial retirements in the next 5 years for the rheumatology department 14. Planned Senior/Lead Nurse Specialist retirements/partial retirements in the next 3 years 15. Planned Senior/Lead Nurse Specialist retirements in the next 5 years for the rheumatology department
Date of Response: 21/10/2026
View Response: 11968.pdf
Freedom of Information Request Reference: 11966
Date Received: 24/09/2026
Summary:
To request information concerning interventional cardiology procedures performed by the Trust and the coronary stents and balloon catheters purchased by it. I would be grateful if you could provide the following information for each of the following financial periods: • 2023/24 • 2024/25 • 2025/26 Please provide information relating to the following interventional cardiology device categories: 1. Drug-Eluting Coronary Stents (DES) 2. Drug-Coated Balloons (DCB) 3. Semi-Compliant Coronary Angioplasty Balloons A. PROCEDURE / DEVICE VOLUMES For each financial year or period, please provide: 1. The total number of PCI procedures performed by the Trust. 2. The total number of coronary stents used or purchased. 3. The total number of coronary balloon catheters used or purchased. B. DEVICE PRICING AND EXPENDITURE For each manufacturer and product identified above, please provide: 1. Manufacturer name. 2. Product/brand name. 3. Number of units purchased. 4. Actual unit price paid by the Trust, excluding VAT. 5. Total expenditure, excluding VAT. 6. Supplier or distributor name, where recorded.
Date of Response: 20/10/2026
View Response: 11966.pdf
Freedom of Information Request Reference: 11962
Date Received: 24/09/2026
Summary:
Please could I request the following information; 1. How many Urology consultants (FTE) are employed by the board. 2. How many ENT consultants (FTE) are employed by the board. 3. a. Does the board provide inpatient care for Urology. b. If inpatient care is provided what location is it provided at. 4. a. Does the board provide inpatient care for ENT. b. If inpatient care is provided what location is it provided at. 5. a. Does the board perform Emergency Surgery for Urology. b. If Emergency Surgery is performed what location is it performed at. 6. a. Does the board performed Emergency Surgery for ENT. b. If Emergency Surgery is performed what location is it performed at. 7. a. Does the board perform Cancer Surgery for Urology. b. If Cancer Surgery is performed what location is it performed at. 8. a. Does the board perform Cancer Surgery for ENT. b. If Cancer Surgery is performed what location is it performed at.
Date of Response: 21/10/2026
View Response: 11962.pdf
Freedom of Information Request Reference: 11961
Date Received: 23/09/2026
Summary:
With regards to the pilot GP walk-in centre located in Wester Hailes: • What is the staffing composition of the GP walk-in centre. • What funding was allocated to deliver the GP walk-in centre's operation in financial year 2026-27. • A copy of the final funding bid submitted to Scottish Government by the health board. • What is the maximum weekly appointment capacity at GP walk-in centre.
Date of Response: 20/10/2026
View Response: 11961.pdf
Freedom of Information Request Reference: 11960
Date Received: 23/09/2026
Summary:
To ask how many cases your health board has recorded of a patient being admitted following a drug overdose or poisoning to emergency units. Could this be broken down by the following years. 2021/22 2022/23 2023/24 2024/25 2025/26
Date of Response: 16/10/2026
View Response: 11960.pdf
Freedom of Information Request Reference: 11956
Date Received: 23/09/2026
Summary:
1. the whole time equivalent number of art therapists employed by NHS Lothian by their grade 2. The average total caseload of an individual Art therapist at any one time (by grade if possible or as an average: please state which) 3. The average individual face to face client interactions in a week 4. The number of face to face group sessions (2 or more people) in a week (not counting family members etc attending in a support role) 5. If possible, an estimation of the % of a therapist's time taken up by 3) and 4) combined (ie the % of face to face contact time as opposed to other administrative tasks including report) writing)
Date of Response: 20/10/2026
View Response: 11956.pdf
Freedom of Information Request Reference: 11953
Date Received: 22/09/2026
Summary:
I'm getting in touch regarding new figures showing that more than £10m has been paid to the private operator of the Royal Infirmary of Edinburgh (RIE) to keep parking at the hospital free. Figures released by NHS Lothian under freedom of information laws show the cost of the keeping the car park free of charge, including operational costs, is £400,000 a quarter. Could I please see these figures?
Date of Response: 20/10/2026
View Response: 11953.pdf
Freedom of Information Request Reference: 11951
Date Received: 22/09/2026
Summary:
Please provide any information you hold relating to: • Average or median prescribing rates for NHS dentists in 2018, including the units and denominators used to calculate those rates. • Comparative prescribing rates for the listed preparations, including sodium fluoride toothpaste 5000 ppm and Fluoride Mouthwash and Amoxicillin capsules, with a breakdown by strength where available. • NHS Board, regional and national comparator data across all of Scotland. • The prescribing-monitoring methodology used by Practitioner Services in 2018, and any equivalent methodologies used elsewhere in the UK that you hold. • Any thresholds or criteria used at that time to identify unusual or atypical dental prescribing.
Date of Response: 20/10/2026
View Response: 11951.pdf
Freedom of Information Request Reference: 11950
Date Received: 21/09/2026
Summary:
As at 22 July 2026, you reported combined neurodevelopmental figures (ADHD and autism together) of adults 177 weeks median / 12,769 waiting, and under-18 (CAMHS) 141.5 weeks median / 12,275 waiting. I request: 1. The current equivalent of those four figures, on the same combined basis, as at the most recent date for which data is held. 2. For the adult list and the under-18 list: the longest current wait of anyone on the list, and the number who have currently waited more than two years. 3. The number of neurodevelopmental assessments completed in the most recent 12 months for which data is held, for adults and for under-18s. 4. If ADHD and autism referrals can now be reported separately, the separated figures; if not, no breakdown is requested.
Date of Response: 20/10/2026
View Response: 11950.pdf
Freedom of Information Request Reference: 11949
Date Received: 17/09/2026
Summary:
1. Total spend in the last complete financial year on interim, agency or contract staff working in project management, programme management, PMO, business change or ICT infrastructure roles broken down by supplier or agency where that is held. 2. The number of such interim or contract workers engaged at the date of this request, by role type. 3. The name of any framework, agency agreement or managed service provider through which those workers are engaged.
Date of Response: 20/10/2026
View Response: 11949.pdf
Freedom of Information Request Reference: 11947
Date Received: 17/09/2026
Summary:
1. The name and job title of the most senior officer responsible for ICT, digital and technology (for example the Chief Information Officer, Chief Digital Officer, Head of ICT or equivalent), and the business email address and business telephone number published or used for that role. 2. The name and job title of the officer responsible for the delivery of ICT, network and business-systems projects, if that is a different person, with the same business contact details. 3. The name and job title of the officer who owns the organisation's telephony and network contracts, if that is a different person again.
Date of Response: 09/10/2026
View Response: 11947.pdf
Freedom of Information Request Reference: 11946
Date Received: 21/09/2026
Summary:
How many thousands of paper prescription forms have been purchased in each of the past 5 financial years?
Date of Response: 14/10/2026
View Response: 11946.pdf
Freedom of Information Request Reference: 11945
Date Received: 21/09/2026
Summary:
What has been the spend in each of the past 5 financial years in respect of paper prescription supplies?
Date of Response: 16/10/2026
View Response: 11945.pdf
Freedom of Information Request Reference: 11944
Date Received: 21/09/2026
Summary:
Please provide all meeting agendas, minutes and papers for meetings of the Scotland East finance directors. Please provide such information for March and February 2026. I understand the region is a collaboration of several boards so please provide information held by NHS Lothian.
Date of Response: 20/10/2026
View Response: 11944.pdf
Freedom of Information Request Reference: 11941
Date Received: 18/09/2026
Summary:
Q1. How many patients received treatment for any condition in the last six months with any of the following treatment regimens (March 2026 – August 2026)? • Ocrevus (ocrelizumab) IV • Ocrevus (ocrelizumab) Subcutaneous • Kesimpta (ofatumumab) • Briumvi (ublituximab) • Mavenclad (cladribine) • Dimethyl Fumarate (Tecfidera + Dimethyl Fumarate generic) • Vumerity (diroximel fumarate) • Tysabri (natalizumab) IV • Tysabri (natalizumab) Subcutaneous • Tyruko (natalizumab biosimilar) • Any Other Platform Therapies (interferon Beta, peginterferon beta-1a, teriflunomide, glatiramoids) • S1P Receptor Modulators (fingolimod, siponimod, ponesimod, ozanimod) Q1a. Of the patients identified in question one, how many of the same patients received treatment with each treatment regimen in November 2025-April 2026 AND March 2026 – August 2026)? • Ocrevus (ocrelizumab) IV • Ocrevus (ocrelizumab) Subcutaneous • Kesimpta (ofatumumab) • Briumvi (ublituximab) • Mavenclad (cladribine) • Dimethyl Fumarate (Tecfidera + Dimethyl Fumarate generic) • Vumerity (diroximel fumarate) • Tysabri (natalizumab) IV • Tysabri (natalizumab) Subcutaneous • Tyruko (natalizumab biosimilar) • Any Other Platform Therapies (interferon Beta, peginterferon beta-1a, teriflunomide, glatiramoids) • S1P Receptor Modulators (fingolimod, siponimod, ponesimod, ozanimod) Q2. How many patients have received a new diagnosis for Multiple Sclerosis in the latest six-month period (March 2026 – August 2026)? Q2a. Of the patients identified in question two, how many of these patients have received any of the following treatment regimens as their first treatment following their Multiple Sclerosis diagnosis? • Ocrevus (ocrelizumab) IV • Ocrevus (ocrelizumab) Subcutaneous • Kesimpta (ofatumumab) • Briumvi (ublituximab) • Mavenclad (cladribine) • Dimethyl Fumarate (Tecfidera + Dimethyl Fumarate generic) • Vumerity (diroximel fumarate) • Tysabri (natalizumab) IV • Tysabri (natalizumab) Subcutaneous • Tyruko (natalizumab biosimilar) • Any Other Platform Therapies (interferon Beta, peginterferon beta-1a, teriflunomide, glatiramoids) • S1P Receptor Modulators (fingolimod, siponimod, ponesimod, ozanimod)
Date of Response: 20/10/2026
View Response: 11941.pdf
Freedom of Information Request Reference: 11940
Date Received: 18/09/2026
Summary:
1. How many third sector or not-for-profit organisations are currently involved in supporting discharge for patients aged 50 and over. 2. The name of each organisation. 3. Which of the following services each organisation provides, where this information is available: • Discharge planning and support • Preparing the home for return, for example heating, food or tidying • Transport to the home • Settling into the home • Assistance with shopping and/or medication while at home 4. When each current programme or contract began. 5. Whether the programme or contract has a scheduled end date and, if so, when this is.
Date of Response: 16/10/2026
View Response: 11940.pdf
Freedom of Information Request Reference: 11937
Date Received: 18/09/2026
Summary:
I am requesting: 1. Software asset and contract registers If NHS Lothian maintains any of the following, please provide the current version: • a software asset register or application register • an ICT or digital contract register Please supply these in machine-readable form (Excel) rather than PDF if possible. If any field in a register is exempt, please provide the register with that field removed rather than withholding it in full. 2. Expenditure on named suppliers For the financial year 2025/26, please state the total expenditure on products and services originating from each of the following: • (a) Microsoft • (b) Oracle • (c) Amazon Web Services Please include spend made through a reseller, licensing solution provider, systems integrator, managed service provider or public sector framework, as well as any spend made directly with the supplier. 3. Licence and subscription volumes As at 31 March 2026, please state the number of licences or subscriptions held for each of the following categories: • Microsoft Windows (desktop and server operating systems) • Microsoft 365 / Office • All other Microsoft products (including Dynamics, SQL Server and Azure subscriptions) • Oracle database products • Oracle application products • All other Oracle products If licences are held under an enterprise agreement or similar arrangement that does not record a per-user count, please say so and give the metric that is used instead. 4. Total software expenditure For the financial year 2025/26: • (a) total expenditure on all software licences, subscriptions and cloud services • (b) a list of every software or cloud supplier on which NHS Lothian spent more than £50,000, with the amount spent on each
Date of Response: 21/10/2026
View Response: 11937.pdf
Freedom of Information Request Reference: 11933
Date Received: 17/09/2026
Summary:
Please provide the following information about the Chalmers Gender Identity Clinic. For each year from 2015/16 to 2025/26 (financial years, or calendar years if that is how you hold the data), please provide: 1. The number of referrals accepted onto the waiting list. 2. Of those referrals (grouped by the year the referral was received), the number who: a. completed assessment and were diagnosed with gender incongruence (ICD-11 HA60/HA61) or gender dysphoria / transsexualism (ICD-10 F64.x); b. completed assessment and were not given that diagnosis; c. were discharged or taken off the waiting list before assessment was complete, broken down by reason if recorded (for example: patient withdrew, did not attend, moved out of area, transferred to another service, died, other/unknown); d. are still waiting for, or still going through, assessment. 3. If you cannot group the data by year of referral, please give the number of assessments completed each year and, of those, how many ended in a diagnosis as described in 2a.
Date of Response: 12/10/2026
View Response: 11933.pdf
Freedom of Information Request Reference: 11931
Date Received: 17/09/2026
Summary:
I am writing to make a Freedom of Information (FOI) request for all communications between NHS Lothian and the Scottish Government in relation to the Independent External Review of Skye House. I would be grateful if you could provide copies of all communications between the Scottish Government and NHS Lothian relating to the Independent External Review of Skye House.
Date of Response: 09/10/2026
View Response: 11931.pdf
Freedom of Information Request Reference: 11928
Date Received: 17/09/2026
Summary:
Please provide the following information regarding the financial administration, expenditure, and structural management of the Regional Long Covid / ME/CFS Multidisciplinary (MDT) Service Consortium (comprising NHS Borders, NHS Fife, NHS Forth Valley, and NHS Lothian). According to the consortium’s draft service framework and Memorandum of Understanding (MOU), NHS Lothian operates as the designated Host Board responsible for regional recruitment, payroll administration, and the retention of regional services business data. Please provide: 1. Line-by-Line Financial Ledger: A detailed, itemised breakdown of all actual and projected expenditure drawn from the £385,829 pooled fund allocated to the "Regional Model Split" for the current financial planning cycle. 2. Workforce and Staffing Expenditure: The exact staffing models, Whole Time Equivalent (WTE) figures, and respective Agenda for Change (AfC) or medical consultant salary bands funded by this regional pool. Please specify the exact amounts allocated to the Strategic/Clinical AHP Lead, Clinical Psychologist, Programme Manager, and Administrative/Medical Secretary roles. 3. Consortium Governance Records: Copies of all minutes, action logs, and financial briefing papers generated by the Regional Long Covid/ME/CFS Steering Group and the Regional Clinical Sub-Group from January 2026 to the present date. 4. Inter-Board Resource Agreements: Copies of the finalized or most recent draft versions of the Shared Service Agreements or Service Level Agreements (SLAs) governing the 29.01% financial siphon from participating boards (specifically referencing the £28,787 extracted from NHS Borders). 5. Biomedical Prescribing Provisions: Any service specifications, clinical triage pathways, or risk assessment matrices detailing how the siphoned regional funding provides tertiary medical authority or legal indemnity for community General Practitioners (GPs) to prescribe autonomic and cardiovascular treatments for severe neurogenic orthostatic hypotension (nOH).
Date of Response: 20/10/2026
View Response: 11928.pdf
Freedom of Information Request Reference: 11926
Date Received: 16/09/2026
Summary:
I would like to request information relating to the funding, expenditure, and financial governance of maternity services within your NHS Board area. 1. Maternity Services Expenditure Please provide the total annual expenditure on maternity services for each financial year from 2019-20 to 2025-26 (or the most recent year available), with a breakdown, if possible, between hospital services and community services. 2. Funding Sources Please provide information on: • The sources of funding for maternity services within the Board. • Any ring-fenced maternity, neonatal, or women's health funding received between 2019-20 and 2025-26. • Details of any specific funding allocations received from the Scottish Government for The Best Start implementation. 3. Funding Allocation and Decision-Making Please explain how funding allocations are determined for maternity services within the board, including: • The governance process for making funding and allocation decisions related to maternity services. • Copies of any financial reports, evaluations, or monitoring reports that discuss the costs of implementing The Best Start.
Date of Response: 20/10/2026
View Response: 11926.pdf
Freedom of Information Request Reference: 11924
Date Received: 16/09/2026
Summary:
I am writing to request an update regarding the nationwide tracking, compliance, and financial allocation data held by the Scottish Government concerning the Delivery Framework for Miscarriage Care in Scotland. Please provide the following information: 1. From the standardized monitoring framework documents and action plan templates submitted to the Scottish Government by the 14 regional NHS Boards, please provide: a. The exact nationwide percentage or breakdown of the 34 deliverables currently marked as ‘Fully Completed’, ‘In Progress’, or ‘Not Started’ across Scotland. b. A summary table or spreadsheet showing the completion/in-progress status of each individual standard (across Tiers 1,2, and 3) mapped against all 14 NHS Boards. c. For any Tier 1 or Tier 2 standards not yet universally completed across all 14 boards, please provide the recorded reasons for the delay and the adjusted forecasted dates for full nationwide compliance. 2. Regarding the £1.5 million allocated nationally to support NHS Boards with this rollout: a. A breakdown of the exact financial allocations distributed to each of the 14 regional NHS Boards. b. Any central audit data/expense logs held by the government that detail how these funds were utilized by the boards. Specifically, identifying the proportions spent on structural hospital upgrades (e.g., dedicated units) versus general midwifery staffing or clinical backfill. 3. Regarding nationwide physical space and facility audits: a. The total number and names of hospitals across Scotland that have been logged by the government as having fully functional, operational private rooms or dedicated early pregnancy spaces for patients who are experiencing loss that are separate from active labour and/or maternity wards. b. The total number and names of hospitals that are currently logged as non-compliant or still undergoing structural adaptations to meet this specific space mandate.
Date of Response: 09/10/2026
View Response: 11924.pdf
Freedom of Information Request Reference: 11923
Date Received: 16/09/2026
Summary:
I request the following recorded information relating to the group known as Queer Milk or the Queer Milk Collective: 1. Any recorded information held by NHS Lothian regarding this group, including correspondence, meeting notes, briefings or referral arrangements. 2. Any recorded information indicating whether NHS Lothian staff have attended, facilitated, referred patients to, or signposted patients to this group. 3. Any guidance or material held by NHS Lothian which names or signposts to this group. 4. Any recorded clinical, safeguarding or governance risk assessment undertaken in relation to this group.
Date of Response: 12/10/2026
View Response: 11923.pdf
Freedom of Information Request Reference: 11922
Date Received: 16/09/2026
Summary:
1. Copies of any evidence appraisal, literature review, application form or supporting documentation considered by the East Region Formulary Committee in relation to the treatment pathway "ADULT — augmentation of lactation" approved at its meeting of 30 March 2022. 2. Copies of any evidence appraisal, literature review, formulary amendment form or supporting documentation considered in relation to the amendment for domperidone for augmentation of lactation agreed at the East Region Formulary Committee in May 2025. 3. Any recorded information indicating whether the Committee considered, at either the 2022 or 2025 review, the application of this pathway to the induction of lactation in non-gestational parents. 4. Any recorded consideration by the Committee of the Medicines and Healthcare products Regulatory Agency's 2014 restrictions on domperidone in relation to this pathway. 5. Any recorded information held regarding the transfer of domperidone into milk, or infant exposure to domperidone, where lactation has been pharmacologically induced rather than augmented following pregnancy.
Date of Response: 12/10/2026
View Response: 11922.pdf
Freedom of Information Request Reference: 11921
Date Received: 16/09/2026
Summary:
I would like to request the following recorded information under the Freedom of Information (Scotland) Act 2002 in relation to your organisation’s preparations for the Terrorism (Protection of Premises) Act 2025, commonly known as Martyn’s Law. 1. Responsibility Please provide the name or job title of the officer, department or team currently responsible for your organisation’s preparations for, and implementation of, the Terrorism (Protection of Premises) Act 2025 / Martyn’s Law. 2. Current plans and preparations Please confirm whether your organisation currently holds any documented plan, action plan, implementation plan, risk assessment, internal report or other recorded document relating to preparations for the Terrorism (Protection of Premises) Act 2025 / Martyn’s Law. If so, please provide copies of those documents, subject to any applicable exemptions. 3. Actions and timescales Please provide details of any recorded actions, milestones or implementation dates that have been agreed in relation to preparing your organisation or its premises for the requirements of the Act. 4. Budget Please confirm whether any budget, anticipated expenditure or financial provision has been identified or allocated for work associated with the Terrorism (Protection of Premises) Act 2025 / Martyn’s Law. If a figure has been identified or allocated, please provide the amount. 5. Exercises and drills Please confirm whether your organisation has carried out, commissioned or scheduled any lockdown, evacuation, invacuation, terrorism-response or similar emergency exercises or drills during the last 24 months.
Date of Response: 20/10/2026
View Response: 11921.pdf
Freedom of Information Request Reference: 11918
Date Received: 15/09/2026
Summary:
I would also be grateful for the following additional recorded information about out-of-hours provision: 1. The operating hours of CAMHS Meadows, Meadows West Lothian and the CAMHS Tier 3 and Tier 4 services identified in your response, including evening, weekend and public-holiday availability. 2. Outside those hours, what NHS-provided or commissioned service or pathway is available to a neurodivergent child under 18 experiencing an acute trauma-related crisis, suicidal distress or risk of self-harm? 3. For any such provision, please provide its age criteria, access/referral route, hours of availability, and whether specialist CAMHS advice or assessment is available during those hours. Please make clear any differences in provision for children under 16 and those aged 16–17. 4. Any recorded arrangements enabling children who cannot provide a detailed verbal account, or cannot use telephone-based support, to access that out-of-hours provision, including available communication adaptations.
Date of Response: 20/10/2026
View Response: 11918.pdf
Freedom of Information Request Reference: 11909
Date Received: 11/09/2026
Summary:
I am seeking information concerning the use of taxis, blood bike services or charitable/voluntary organisations to transport items between NHS facilities and to or from other locations. For the purposes of this request, “items” includes, but is not limited to, blood products, blood samples, pathology specimens, laboratory samples, medicines, prescriptions, medical supplies, clinical equipment, documents, records and any other NHS-related materials transported by a third-party or external transport provider. Where possible, I would appreciate the information for the last complete financial year (2024/25 to 2025/26), together with any available information for the current financial year (2026/27) up to the date of this request. 1. Taxi/private-hire vehicle use Please provide: 1. The total number of taxi/private-hire vehicle journeys commissioned or paid for by the Health Board for the transportation of NHS items for each financial year. 2. The total number of individual items transported by taxi/private-hire vehicle for each financial year, where this information is recorded. 3. Where available, a breakdown of the types of items transported by taxi/private-hire vehicle, for example: o Blood/blood products o Blood samples o Pathology/laboratory specimens o Medicines/pharmaceuticals o Medical supplies o Clinical equipment o Documents/records o Other items 4. The total expenditure on taxi/private-hire vehicle transportation of NHS items for each financial year. 5. The number of individual taxi/private-hire companies or suppliers used for this purpose in each financial year. 6. Where available, the number or percentage of journeys undertaken under: o Contracted arrangements o Ad-hoc bookings o Emergency/out-of-hours arrangements o Other arrangements 7. Where available, the average or typical cost per journey or if a fixed cost, this fixed cost per journey/item. 8. Where available, the average distance travelled per journey. 2. Blood bike services Please provide: 1. The number of journeys undertaken by blood bike services on behalf of the Health Board for each financial year. 2. The number of individual items transported by blood bike services for each financial year. 3. A breakdown of the types of items transported by blood bike services, where recorded, including: o Blood/blood products o Blood samples o Pathology/laboratory specimens o Medicines/pharmaceuticals o Medical supplies o Clinical equipment o Documents/records o Other items 4. The total expenditure paid by the Health Board to blood bike organisations for each financial year. 5. The names of the blood bike organisations used by the Health Board. 6. Whether each blood bike organisation provides its service: o Free of charge o Under a formal contract o Under a service-level agreement o Through another funding arrangement 7. Where available, the estimated value of the service provided by blood bike organisations where the service is provided free of charge. 3. Charities and voluntary organisations other than Blood Bike charities Please provide: 1. The number of journeys undertaken by charitable, voluntary or community organisations to transport NHS items for each financial year. 2. A breakdown, where available, of the types of items transported. 3. The total amount paid by the Health Board to charitable, voluntary or community organisations for transportation services for each financial year. 4. Where services were provided free of charge, please state this and, where an estimated financial value has been recorded, provide that value. 5. Where available, the number of journeys and items transported by each individual organisation. 4. Procurement and contracts Please provide details of any current contracts, framework agreements or other formal procurement arrangements relating to the transportation of NHS items by: • Taxi/private-hire vehicles • Courier companies • Blood bike organisations • Charitable/voluntary organisations • Other third-party transport providers For each arrangement, please provide where available: • Supplier/provider name • Contract start date • Contract end date • Contract value • Annual expenditure • Nature of the service • Whether the contract was competitively tendered • Contract reference number I am not requesting copies of contracts if this would create an excessive burden; a summary of the above information would suffice. 5. Out-of-hours and emergency transportation Please provide, where recorded: • Number of out-of-hours transportation journeys • Number of emergency/urgent transportation journeys • Number undertaken by taxi • Number undertaken by blood bike • Number undertaken by charitable/voluntary organisations • Associated expenditure If the Health Board does not separately record emergency or out-of-hours journeys, please state this.
Date of Response: 09/10/2026
View Response: 11909.pdf
Freedom of Information Request Reference: 11903
Date Received: 08/09/2026
Summary:
I would like data on the number of recorded stillbirths and neonatal deaths at the Simpsons Maternity Unit between 1/8/2012 and the 31/12/2012. I would like the dates of these recorded stillbirths or neonatal deaths. I would like data on the number of stillbirths at the Simpsons Maternity unit from 1/8/2012-1/8/2013. I would like data on the number of near misses (datix) recorded, or reported concerns around competency of staff on the unit during the period 1/8/2012 - 31/12/2012.
Date of Response: 20/10/2026
View Response: 11903.pdf
Freedom of Information Request Reference: 11887
Date Received: 07/09/2026
Summary:
May I ask for the following information: Can you tell me how many deaths happened on your A&E wards in each calendar year 2022-2026 to date? Can you also provide numbers as to how many complaints you have had about your A&E wards in each calendar year? How much did your NHS board pay out in compensation for mistakes made by A&E staff during each calendar year? For each case, can you breakdown what the pay-outs were for and for how much?
Date of Response: 20/10/2026
View Response: 11887.pdf
Freedom of Information Request Reference: 11837
Date Received: 18/08/2026
Summary:
I am researching technology modernisation in the Scottish public sector and would be grateful for the following information relating to financial year 2024/25, or the most recent full year for which figures are available: 1. NHS Lothian's total ICT expenditure for 2024/25, broken down between (a) capital investment in new or replacement systems and (b) maintenance, support, and licensing costs for existing systems. 2. The total number of IT systems currently in active use across NHS Lothian, including clinical, administrative, and operational systems. 3. Of those systems, how many are classified as end-of-life, out of active vendor support, or flagged as requiring modernisation — including any systems identified through the Scottish Government Cyber Resilience Strategy or assessed against the UK Government Legacy IT Risk Assessment Framework. 4. The estimated annual cost of maintaining IT systems that are end-of-life or out of vendor support, where that figure is held.
Date of Response: 09/10/2026
View Response: 11837.pdf
Freedom of Information Request Reference: 11747
Date Received: 21/07/2026
Summary:
I would be grateful if you could provide the following information relating to undergraduate medical student travel reimbursement claims associated with NHS clinical placements funded through ACT arrangements. Please provide information for financial years 2022/23, 2023/24 and 2024/25. For each financial year, please provide: 1. The medical school or schools for which the board administers undergraduate medical student travel reimbursement claims. 2. The total number of undergraduate medical student travel reimbursement claims received. 3. The total number of travel reimbursement claims approved. 4. The total number of travel reimbursement claims rejected or partially rejected. 5. The average (mean) number of calendar days between receipt of a claim and payment being made to the student. 6. The shortest recorded time between receipt of a claim and payment being made to the student. 7. The longest recorded time between receipt of a claim and payment being made to the student. 8. The number (or, if more readily available, the proportion) of claims where payment was made more than 28 calendar days after receipt of the claim. 9. The total value of travel reimbursement payments made to undergraduate medical students. 10. A copy of any current guidance, policy or procedure document used by the board in relation to undergraduate medical student travel reimbursement claims.
Date of Response: 09/10/2026
View Response: 11747.pdf
Freedom of Information Request Reference: 11689
Date Received: 08/07/2026
Summary:
FOI request regarding cladding issues at the Royal Hospital for Children and Young People. Can you supply the following information for me: 1) Is the installed cladding system the Alucobond BM system as was specified in the planning application? 2) What is the specification for the core of the ACM panels in this system - i.e. is it the fire resistant type? 3) Can you forward me a copy of the fire test certificate for the installed system? This would require to be submitted to building control by the architect or fire engineer in order to obtain a building warrant. A copy of this certificate should also have been included in the O&M Manual delivered to the Board at handover. 4) Can you advise what the insulation system specification is and can you confirm that it is low risk as required by the Technical Standards? 5) Why was it deemed necessary to change the spacing of the cavity barriers from 20m to 10m if the installed ACM system was fully compliant with the contract requirements? 6) Did the project managers Mott McDonald raise any concerns with you regarding issues with the external cladding as part of their remit to carry out due diligence during the construction phase of the contract?
Date of Response: 09/10/2026
View Response: 11689.pdf
Freedom of Information Request Reference: 11572
Date Received: 09/06/2026
Summary:
I would like to request the following information relating to NDD Pathways in your Health Board Area 1. Does your board have a dedicated pathway for assessment and treatment of NDD? - If so, what are the criteria for entry to this pathway? 2. What are the criteria for assessment and treatment by your secondary care mental health services and are there any specific exclusion criteria relating to NDD? 3. Is NDD assessed/treated in the absence of mental illness in your boards mental health service? 4. What information is sent to patients and referrers when referral for assessment/treatment of NDD is rejected? 5. Do you have a standard template letter for rejection letters? – If so please provide this 6. Do you accept patients on to secondary care mental health caseload who have been diagnosed and/or treatment commenced by a private provider?- If so is it all referrals and if not how do you triage? 7. What arrangements does your board have in place for patients who commence treatment for NDD under CAMHS services when they reach adult age? 8. Does your board or service have a position statement on assessment and treatment of NDD? - If so can this be provided? 9. What specific NDD training if any have your staff received 10. Has Lived Experience feedback been involved in any developments within your service for NDD?
Date of Response: 16/10/2026
View Response: 11572.pdf
Freedom of Information Request Reference: 11487
Date Received: 12/05/2026
Summary:
I write to request information relating to NHS Lothian (NHSL) cataract services, specifically in relation to triage processes and waiting list management. • Current triage criteria and pathways used for cataract referrals, including any clinical prioritisation guidance • Policies or standard operating procedures governing cataract waiting lists • Current actual (not target) waiting list times for cataract procedures, including any distinctions by priority category
Date of Response: 16/10/2026
View Response: 11487.pdf
Freedom of Information Request Reference: 11295
Date Received: 13/03/2026
Summary:
Please provide the following information for the period 1 January 2023 to the date of your reply. 1. Has your organisation undertaken any of the following procedures in a clean treatment room rather than in a main operating theatre? Please answer Yes / No for each, and if readily available please provide either the exact number of cases or an approximate number of cases performed in that setting during the period above. a) Entropion repair b) Ectropion repair c) Ptosis repair d) Upper blepharoplasty e) Canthoplasty / canthopexy f) Eyelid reconstruction following lesion excision g) Other eyelid or oculoplastic procedures performed in that setting (please specify) 2. If your organisation performs any of the above in a clean treatment room, please provide copies of any recorded documents that set out: a) case selection or inclusion / exclusion criteria b) local SOPs, policies, pathways, or protocols c) clinical risk assessments relating to undertaking such procedures in that setting d) infection prevention and control assessments, approvals, or sign-off documents e) estates / ventilation / room suitability assessments, if held f) governance approvals, committee papers, or decision records approving this practice, if held 3. If held, please state the room or environment requirements specified by your organisation for carrying out these procedures in a clean treatment room, for example any recorded requirements relating to: a) ventilation or air-handling standard b) staffing model c) monitoring / resuscitation equipment d) maximum anticipated procedure duration e) whether procedures must be under local anaesthesia only f) whether any procedures are excluded if grafts, flaps, sedation, or reconstruction are involved 4. If held, please provide any recorded audit, surveillance, or governance information for procedures undertaken in a clean treatment room during the same period, including: a) surgical site infection data b) adverse incident or complication data reported by setting c) unplanned transfer to theatre or admission d) any review or audit reports specifically considering the safety or suitability of these procedures in that setting 5. If your organisation does not hold a single document answering any part of the above, please provide the recorded information in the form in which it is held. If any of the requested information is already publicly available, please provide a link to the relevant document or webpage.
Date of Response: 16/10/2026
View Response: 11295.pdf
Freedom of Information Request Reference: 11545
Date Received: 02/06/2026
Summary:
Please can you provided the number of admissions to your NICU and number of times the NICU has been closed at Royal Infirmary of Edinburgh from 2021 - 2026 and the reason why.
Date of Response: 18/08/2026
View Response: 11545.pdf
Freedom of Information Request Reference: 11520
Date Received: 22/05/2026
Summary:
I request all information held in relation to the following: 1. Policy Documentation Formal and informal written policy documents relating to the practice of writing to patients to advise that will be removed from the neurodevelopmental assessment waiting list if they fail to respond, including the date of introduction, the name and role of the person or body who approved it, and any subsequent reviews. 2. Projected Impact Any analysis, modelling, briefing, or other documentation relating to the anticipated or projected impact of the policy, including: (a) the number of patients expected to be removed from the waiting list as a result; (b) the basis on which that figure was considered acceptable; (c) any assessment of whether patients removed would genuinely no longer require assessment, as opposed to having simply failed to respond to correspondence; (d) consideration of how to ensure that patients have actually received the letter or text message. 3. Aim of policy Any documentation setting out the operational, clinical, or administrative problem the policy was intended to solve, and the benefit it was expected to deliver. 4. Equalities Any equalities impact assessment (or equivalent) carried out before or after the introduction of the policy, including any consideration of the specific impact on patients with neurodevelopmental conditions, for whom challenges in communication and executive functioning can be key disabling features of their condition. 5. Scope of policy Any information confirming whether this policy applies to other waiting lists or clinical specialties within NHS Lothian, or whether it is specific to the neurodevelopmental assessment waiting list. 6. Outcomes to date The number of patients who have been removed from the neurodevelopmental assessment waiting list under this policy since its introduction, and the total number contacted. 7. Internal correspondence Any internal emails, minutes, briefings, or other communications discussing the rationale for introducing the policy or any concerns raised about it prior to or following implementation. 8. Parliamentary Inquiries Any consideration of the recommendations of Scottish Parliament inquiries from the past year.
Date of Response: 24/06/2026
View Response: 11520.pdf
Freedom of Information Request Reference: 11997
Date Received: 05/10/2026
Summary:
Request in relation to medical record.
Date of Response: 05/10/2026
View Response: 11997.pdf
Freedom of Information Request Reference: 11939
Date Received: 15/09/2026
Summary:
Please could you provide the following information for each of the technology service categories listed below: 1. The name of the current supplier(s) providing this service. 2. The annual or total contract value. 3. The contract start date and the date it is due to expire or next be reviewed/renewed. Categories: • Network firewall, VPN, or perimeter security • Endpoint protection or antivirus • Network or threat detection and response (e.g. SIEM, NDR) • Email security or anti-phishing • Vulnerability management or security scanning
Date of Response: 07/10/2026
View Response: 11939.pdf
Freedom of Information Request Reference: 11932
Date Received: 17/09/2026
Summary:
I am trying to get an estimate of 2026 waiting list times for an audiology appointment in NHS Lothian.
Date of Response: 07/10/2026
View Response: 11932.pdf
Freedom of Information Request Reference: 11927
Date Received: 16/09/2026
Summary:
I would therefore be grateful if the Council could provide the following information: 1. **Feasibility work:** What feasibility work or assessment was undertaken following the 2021 motion calling for GP and primary care provision in Wallyford? Please provide copies of any relevant reports, assessments, correspondence, meeting minutes or recommendations. 2. **Decision not to proceed with the NHS site:** What reasons were provided by the NHS for deciding not to acquire, lease or otherwise make use of the site identified for an NHS facility within Area 5? Please provide any correspondence or documentation held by the Council relating to this decision. 3. **Population and GP provision assumptions:** What population projections, patient numbers, GP-to-population ratios, capacity assessments, or other assumptions were used when assessing whether a GP surgery or primary care facility in Wallyford was viable or necessary? 4. **Alternative sites and future provision:** Has the Council, NHS Lothian or any other relevant public body identified or considered an alternative site in Wallyford for a GP surgery or other primary care facility? If so, please provide details of the sites considered and the status of any proposals.
Date of Response: 07/10/2026
View Response: 11927.pdf
Freedom of Information Request Reference: 11925
Date Received: 16/09/2026
Summary:
Could you please provide me with details of any 'redeployment pool' or 'redeployment register' operated by the health board. Please also send me a copy of any formal policy regarding the operation of the pool. By redeployment pool/register, I mean any mechanism for workers whose roles are no longer required, but instead of being made redundant, continue to be employed with a view to an alternative role being found for them. Can you please provide the following: - how many employees are currently in your redeployment poll? - of these workers, please specify how many have been in the pool for; under one year, 1-2 years, 2-3 years, 3-4 years, 4-5 years, five years or more. - if a worker has been in the pool for five years or more, the total time, to the closest year, they have been in the pool. - the current monthly cost to the organisation of employing workers who are in the redeployment pool, inclusive of NI costs, pension contributions, etc.
Date of Response: 07/10/2026
View Response: 11925.pdf
Freedom of Information Request Reference: 11917
Date Received: 10/09/2026
Summary:
We would be obliged if you would provide the following information: • Confirmation that Pinnacle Roofing (Scotland) Ltd was the contractor carrying out roof works on or around the index date at Western General Hospital, Crewe Road, Edinburgh, EH4 2XU, • Confirmation of the scope of work being carried out by Pinnacle Roofing (Scotland) Ltd, • Dates Pinnacle Roofing (Scotland) Ltd attended Western General Hospital to carry out works, • We note that a roof tile fell prior to the index accident on 6 February 2026, please provide the circumstances and details of this incident along with any investigations, maintenance, remedial works, risk assessments or safe systems of work put in place prior or subsequent to this event, • Please detail any other instances where roof tiles or other roof objects have feel from the ceiling during the contractual works being carried out by Pinnacle Roofing (Scotland) Ltd, • Please detail any investigations which have taken place prior to the index event and the incident on 6 February 2026, • Please provide details of any risk assessments or safe systems of work detailed prior to or after our client’s index accident related to the work being carried out by Pinnacle Roofing (Scotland) Ltd, • Please detail any measures taken in response to our client’s accident.
Date of Response: 07/10/2026
View Response: 11917.pdf
Freedom of Information Request Reference: 11916
Date Received: 15/09/2026
Summary:
1. How many of the following intra-vitreal injections/implants has your trust administered in the four-month period from May to August 2026: • Aflibercept – Eylea only (Any strength: 2mg or 8mg) • Aflibercept – Eylea 8mg only (21mg/184microlitres solution or 30.1mg/263microlitres solution) • Aflibercept - Biosimilar (any brand other than Eylea) • Bevacizumab • Dexamethasone • Faricimab • Fluocinolone acetonide • Ranibizumab - including all Biosimilars
Date of Response: 07/10/2026
View Response: 11916.pdf
Freedom of Information Request Reference: 11915
Date Received: 15/09/2026
Summary:
Please provide the following information for Priority 2 (P2) surgery for each month from May 2022 to September 2022 inclusive: 1. The number of patients waiting for P2 surgery at the end of each month. 2. The number of patients who underwent P2 surgery during each month. 3. The waiting time for P2 surgery, preferably broken down into: o the median waiting time; o the mean waiting time, if available; and o the number and/or percentage of patients waiting more than 4 weeks, 8 weeks and 12 weeks. 4. The longest waiting time recorded for a patient awaiting P2 surgery in each month. 5. If available, please provide the above information broken down by surgical specialty.
Date of Response: 07/10/2026
View Response: 11915.pdf
Freedom of Information Request Reference: 11912
Date Received: 11/09/2026
Summary:
I have a freedom of information request related to the diagnosis and treatment of Spinal Muscular Atrophy. Your answers to the following questions would be greatly appreciated. Question 1. Within your trust, how many patients currently have a diagnosis for: SMA Type 1, aged less than 6 months (ICD-10 Code G12.0) SMA Type 2, aged 6–17 months (ICD-10 Code G12.1) SMA Type 3, aged 18 months–17 years (ICD-10 Code G12.1) SMA Type 4, aged 18 years and over (ICD-10 Code G12.1) SMA Unspecified (ICD-10 Code G12.9) Question 2. Please provide the number of total patients and new patients* who have been treated in the last 4 months (May to August 2026) with the following products: Drug Type Total Patients New Patients* Evrysdi (Risdiplam) Total Tablets Oral Solution Spinraza (Nusinersen) Total 12 mg/5 mL Intrathecal Injection 28 mg/5 mL Intrathecal Injection Zolgensma (Onasemnogene) Total *New patients are defined as patients who were not treated with any of Spinraza (Nusinersen), Evrysdi (Risdiplam), or Zolgensma (Onasemnogene abeparvovec) in the previous 4-month period (January to April 2026). Patients who switch between formulations, strengths, or routes of administration of these therapies are not considered new patients. Question 3. Of the total patients treated in the last 4 months (May to August 2026) with Evrysdi (Risdiplam), please provide the number of patients that were treated with Spinraza (Nusinersen) in the previous 4 months (January to April 2026). Question 4. Of the total patients treated in the last 4 months (May to August 2026) with Zolgensma (Onasemnogene), please provide the number of patients that were treated with Spinraza (Nusinersen) in the previous 4 months (January to April 2026). Question 5. Of the total patients treated in the last 4 months (May to August 2026) with Spinraza (Nusinersen), please provide the number of patients that were treated with Evrysdi (Risdiplam) in the previous 4 months (January to April 2026).
Date of Response: 07/10/2026
View Response: 11912.pdf
Freedom of Information Request Reference: 11911
Date Received: 09/09/2026
Summary:
please provide the following information about the Trust's purchasing of peripheral intravenous cannulas. For each of the financial years 2023/24, 2024/25 and 2025/26, please provide: 1. the manufacturer and brand of each product purchased; 2. the catalogue or product code (NPC, or the Trust's own code); 3. the quantity purchased (please state the unit - e.g. each, box, case); 4. the total expenditure, excluding VAT; 5. the name of the supplier the Trust purchased from, where this differs from the manufacturer (for example NHS Supply Chain or another distributor); 6. the contract or framework under which the purchase was made, and its start and end dates; 7. where the Trust changed supplier or manufacturer during this period, the previous supplier or manufacturer and the date of change.
Date of Response: 02/10/2026
View Response: 11911.pdf
Freedom of Information Request Reference: 11906
Date Received: 09/09/2026
Summary:
The aim is to understand how NHS Trusts currently deliver Vascular Access Devices Insertion services, including service structure, leadership, staffing and insertion practices. I would be grateful if you could provide the information requested below: 1. Does your Trust provide: o PICC insertion (Yes/No) o Midline insertion (Yes/No) o Totally Implantable Venous Access Device Chest/Arm insertion (Yes/No) o Tunnelled Central Vascular Access Devices insertion (Yes/No) 2. Who provides these procedures? o Dedicated Vascular Access Team o Interventional Radiology o Anaesthetics o OPAT Service o Nutrition service o Medical Teams o Nursing Teams o Other (please specify) 3. Who performs PICC/Midline insertions? o Nurses o Doctors o Radiographers o Other 4. Who performs TIVAD/Tunnelled VAD insertions? o Nurses o Doctors o Radiographers o Other 5. Where are PICCs/Midlines inserted? Please select all that apply: o Procedure room o Patient bedside o Interventional Radiology o Theatre o Other (please specify) 6. Where are TIVAD/Tunnelled VAD inserted? Please select all that apply: o Procedure room o Patient bedside o Interventional Radiology o Theatre o Other (please specify) 7. Does your Trust have a dedicated Vascular Access Team? (Yes/No) 8. If yes, please provide: o Team composition (e.g. nurses, doctors, advanced practitioners) o Number of staff (WTE if available) o Whether the service is nurse-led, doctor-led, or jointly led 9. Under which department/directorate does the service sit? 10. If readily available, please provide the number of PICCs, Midlines, TIVAD/Tunnelled VAD inserted during the most recent complete financial year.
Date of Response: 07/10/2026
View Response: 11906.pdf
Freedom of Information Request Reference: 11905
Date Received: 10/09/2026
Summary:
Any correspondence between the NHS Lothian chief executive and government ministers about the planned proposals to reduce the number of health boards, dating back to 2024?
Date of Response: 07/10/2026
View Response: 11905.pdf
Freedom of Information Request Reference: 11904
Date Received: 09/09/2026
Summary:
Q1. How many patients were treated by the rheumatology department in the past 3 months with the following: •Tocilizumab – for any disease •Tocilizumab for rheumatoid arthritis (RA) only •Tocilizumab for giant cell arteritis (GCA) only Q2. How many patients were treated by the ophthalmology department (for any disease) in the past 3 months with Tocilizumab? Q3. How many patients were treated in A&E in the past 3 months for giant cell arteritis (GCA) with Tocilizumab? Q4. In the past 3 months, how many patients with a primary diagnosis of GCA (ICD10 codes M31.5 or M31.6) were: •Admitted as an inpatient •Treated in A&E
Date of Response: 01/10/2026
View Response: 11904.pdf
Freedom of Information Request Reference: 11902
Date Received: 08/09/2026
Summary:
I wish to make a Freedom of Information Request for all consultation papers regarding the potential merger of NHS Lothian into other health boards.
Date of Response: 07/10/2026
View Response: 11902.pdf
Freedom of Information Request Reference: 11901
Date Received: 08/09/2026
Summary:
The most up to date timeline for the delivery of a new Princess Alexandra Eye Pavilion, including any delays.
Date of Response: 01/10/2026
View Response: 11901.pdf
Freedom of Information Request Reference: 11900
Date Received: 08/09/2026
Summary:
Please provide all financial expenditure, central funding allocations, specific grants, and research funding allocated by your organization for the following clinical and service areas: 1. Endometriosis (including specialized gynaecological care and diagnostic pathways) 2. Miscarriages/Pregnancy Loss (including early pregnancy assessment units and post-loss support services) 3. Contractual Sexual Health Services (including commissioned STI testing, contraception services, and community sexual health clinics) For each of the three areas above, please provide the total financial figures broken down by the following financial years: - Financial Year 2016/17 - Financial Year 2017/18 - Financial Year 2018/19 - Financial Year 2019/2020 - Financial Year 2020/21 - Financial Year 2021/22 - Financial Year 2022/23 - Financial Year 2023/24 - Financial Year 2024/25 - Financial Year 2025/26 Specification of Data requested: - If exact figures for 2025/26 are not yet finalized or audited, please provide the most up-to-date budgeted allocations or projected spend figures.
Date of Response: 07/10/2026
View Response: 11900.pdf
Freedom of Information Request Reference: 11897
Date Received: 08/09/2026
Summary:
I would be grateful if you could provide the following information for each of the financial years: • 2023/24 • 2024/25 •2026 Please provide the information separately for: 1. Atrial Septal Defect (ASD) closure 2. Patent Foramen Ovale (PFO) closure 3. Left Atrial Appendage Occlusion/Closure (LAAO/LAAC) For each procedure category and financial year, please provide: A. PROCEDURE VOLUMES 1. The total number of ASD closure procedures performed. 2. The total number of PFO closure procedures performed. 3. The total number of LAAO/LAAC procedures performed. B. DEVICE PRICING AND EXPENDITURE For each manufacturer/product identified above, please provide: 1. The actual unit price paid by the Trust, excluding VAT. 2. Supplier/distributor name, where recorded. 3. Procurement route used (NHSSC or other) If the Trust is unable to disclose the exact unit price, please instead provide: • total number of devices purchased, and • total expenditure on that device, so that an average unit cost can be calculated.
Date of Response: 07/10/2026
View Response: 11897.pdf
Freedom of Information Request Reference: 11895
Date Received: 07/09/2026
Summary:
Q1 Please provide me with your evaluation of your ICB's winter plan for 2025-2026 Q2 Please provide the winter plan for 2026-2027.
Date of Response: 07/10/2026
View Response: 11895.pdf
Freedom of Information Request Reference: 11894
Date Received: 07/09/2026
Summary:
Question 1: What are the referral criteria for dementia (memory) assessment within NHS Lothian (i.e., as provided by Older People's Mental Health teams/Memory Assessment and Treatment Service/Older Adult Mental Health team or equivalent)? In other words, on what basis are decisions made whether to accept or reject such referrals? If the criteria vary depending on team/locality, please provide a breakdown. Questions 2: The following prisons fall within the NHS Lothian footprint: HMP Edinburgh (EH11 3LN) and HMP Addiewell (EH55 8QF) For each of the above prisons, does the corresponding dementia (memory) assessment service (i.e., the service covering the geographic area within which the prison is situated) accept referrals from the prison healthcare team of prisoners for the purposes of dementia (memory) assessment, provided all other referral criteria are met? If the answer varies by team, please provide a breakdown. If for any team the answer is no, what is the reason for not accepting such referrals? Question 3: Do NHS Lothian dementia (memory) assessment services accept referrals from prisons outwith the NHS Lothian footprint for prisoners who resided within the NHS Lothian footprint at the time of their incarceration, for the purposes of dementia (memory) assessment? If the answer varies by team, please provide a breakdown.
Date of Response: 01/10/2026
View Response: 11894.pdf
Freedom of Information Request Reference: 11892
Date Received: 07/09/2026
Summary:
For each of 2021/22, 2022/23, 2023/24, 2024/25 and 2025/26 (to date): 1. Number of complaints received that you code to mental health services, CAMHS, and psychological therapies (three rows, or your actual specialty codes — please list the codes). 2. Of those closed in each year: number upheld, partially upheld, and not upheld, by the same service split, and by Stage 1 / Stage 2 if held. 3. Number of SPSO decisions in those years that you record as relating to those services, and how many were upheld or partially upheld, if you hold that.
Date of Response: 08/10/2026
View Response: 11892.pdf
Freedom of Information Request Reference: 11889
Date Received: 07/09/2026
Summary:
Please treat Psychological Therapies (PT) and CAMHS as two separate services. Do not combine them. Please exclude neurodevelopmental / ADHD-only pathways unless you label those rows separately. For each of PT and CAMHS, and for each of financial years 2021/22, 2022/23, 2023/24, 2024/25 and 2025/26 (or calendar years if that is how the extract is held): 1. Of people who started treatment in that year: a. the 95th percentile waiting time in days (say whether adjusted or unadjusted); b. the 99th percentile waiting time in days; c. the number who started after waiting 365 days or more; d. the number who started after waiting 730 days or more. Please do not provide a single maximum if you consider section 38 applies to that one number. I still want (a)–(d). If you only hold completed waits in week bands beyond 104 weeks, give the count in the >104-week band. 2. Of people still waiting to start treatment at the latest extract date you hold: a. the extract date and whether waits are adjusted or unadjusted; b. total still waiting; c. 95th and 99th percentile current wait in days; d. number waiting 365 days or more; e. number waiting 730 days or more. Again, do not provide a single identifiable maximum if section 38 applies. Counts and percentiles are sufficient.
Date of Response: 07/10/2026
View Response: 11889.pdf
Freedom of Information Request Reference: 11882
Date Received: 04/09/2026
Summary:
I am writing to request information under the Freedom of Information (Scotland) Act 2002 relating to the development and selection of locations for GP-led walk-in services within NHS Lothian. Please provide: 1. Any criteria, scoring framework, assessment methodology or other guidance used by NHS Lothian when identifying, assessing or recommending locations for GP-led walk-in services. 2. Any assessments, option appraisals, briefing papers, reports or submissions produced since 1 October 2025 which considered Midlothian as a potential location for a GP-led walk-in service. 3. Details of any locations within Midlothian which have been considered for such a service, including the outcome or current status of that consideration. 4. The registered patient population of each GP practice within the Midlothian Health and Social Care Partnership area for each year from 2021 to 2026, where held. 5. The whole-time-equivalent GP workforce associated with each Midlothian GP practice for each year from 2021 to 2026, where held. 6. The number of contacts with NHS Lothian GP Out of Hours services involving patients resident within Midlothian for each of the financial years 2021/22 to 2025/26, where this information can be provided without identifying individual patients. 7. Any analysis undertaken by NHS Lothian of current or future primary-care capacity requirements arising from population growth, demographic change or housing development within Midlothian.
Date of Response: 07/10/2026
View Response: 11882.pdf
Freedom of Information Request Reference: 11876
Date Received: 02/09/2026
Summary:
I would like to request anonymised statistical information regarding patients who have required unplanned NHS Lothian assessment, treatment and/or admission following complications arising after privately funded cosmetic or plastic surgery. For each of the calendar years 2024, 2025 and 2026 to date, please provide: 1. The total number of patients who required unplanned assessment and/or treatment from NHS Lothian following privately funded cosmetic or plastic surgery. I would be grateful if this is not limited solely to Emergency Department attendances. Where recorded, please include patients who: • attended an Emergency Department; • were transferred or referred from a private hospital/provider; • were referred directly to, admitted under, or assessed by Plastic Surgery, General Surgery or another relevant surgical/specialist team; • were reviewed by an NHS surgeon or plastic surgeon in relation to a postoperative complication; • attended a surgical assessment unit, ward or other NHS service; • or otherwise required unplanned NHS assessment or treatment relating to a complication following privately funded cosmetic or plastic surgery. 2. Of these patients, the number who required admission to an NHS Lothian hospital. 3. Where recorded, please provide a breakdown of the number of patients who required: • emergency or unplanned surgery/re-operation; • treatment for postoperative haemorrhage or haematoma; • treatment for postoperative infection; • treatment for wound complications; • blood transfusion; • inpatient admission or observation following the complication. 4. Where available, please provide a breakdown by the NHS hospital or service which provided the assessment or treatment, including St John’s Hospital, Livingston. 5. Where the treating specialty is recorded, please provide a breakdown by specialty, particularly Plastic Surgery and General Surgery. 6. Where the type of original private procedure is recorded, please provide a breakdown by procedure or category of procedure. In particular, I would be grateful for any figures held relating to complications following breast surgery, including: • breast reduction; • breast augmentation; • mastopexy/breast uplift; • or other cosmetic breast procedures. 7. For the cases included within the figures above, where the originating private hospital/provider is recorded and can be disclosed without identifying an individual patient, please provide the name of the private hospital/provider associated with each case or reported category. For example, where a case involved postoperative haemorrhage/haematoma, infection, wound complication, hospital admission or emergency re-operation, I would be grateful if the originating private provider could also be shown alongside that information where held and where disclosure is permitted. I am not requesting any information capable of identifying the individual patient. I am seeking only the name of the private healthcare provider at which the original privately funded procedure was undertaken. If providing provider information at individual case level would create a risk of patient identification due to small numbers, please instead provide the information grouped by private provider, showing for each provider, where held: • number of patients requiring NHS assessment or treatment; • nature/category of complication; • number requiring NHS admission; • number requiring emergency or unplanned surgery/re-operation; • type/category of original private procedure; • NHS hospital/service providing treatment; • and treating specialty. Within this information, please specifically include St Ellen’s Hospital, Livingston and/or Cosmedicare where they are recorded as the originating private provider. 8. If NHS Lothian cannot provide a complete provider breakdown, please confirm whether St Ellen’s Hospital and/or Cosmedicare can nevertheless be identified within the information held and, if so, please provide the relevant aggregate figures for 2024, 2025 and 2026 to date. 9. Please confirm whether NHS Lothian routinely records the originating private hospital/provider when a patient requires NHS assessment or treatment for a complication following privately funded surgery. If so, please confirm how this information is recorded or coded. If the originating provider is not held as a discrete or routinely reportable field, please confirm whether it may instead be identifiable through routinely recorded information such as: • referral source; • transfer source; • treating specialty; • provider information; • onward referral; • discharge destination; • or follow-up arrangements. 10. Where recorded, please provide the number of patients who, following NHS Lothian assessment, treatment and/or admission for a complication of privately funded cosmetic or plastic surgery, were discharged or referred back to their original private hospital/provider for ongoing postoperative care or follow-up. Where the destination provider can be identified, I would specifically request that the private provider is named alongside the aggregate information where disclosure is possible, including St Ellen’s Hospital and/or Cosmedicare where applicable. If a numerical figure cannot be provided, please confirm whether onward referral, discharge or return to a named private provider is held as a searchable or reportable field. 11. Where NHS Lothian holds information regarding the financial cost of providing unplanned or emergency NHS treatment for complications arising following privately funded cosmetic or plastic surgery, please provide any available aggregate figures for 2024, 2025 and 2026 to date.
Date of Response: 08/10/2026
View Response: 11876.pdf
Freedom of Information Request Reference: 11850
Date Received: 20/08/2026
Summary:
1. How many significant/serious adverse events there has been within maternity and neonatal services between 1st Jan 2019 and 30th June 2026 (If 2026 data not available, until 31st December 2025) - can this be broken down by year and maternity vs neonatal services 2. Can this data then indicate whether it resulted in death, major injury or minor injury, again distinguishing between maternity and neonatal services and by year 3. Can the data from Q1+2 be further broken down by hospital where they occurred 4. From these cases, how many had a significant adverse event review (SAER) commissioned and how many days from the event did they take to complete
Date of Response: 07/10/2026
View Response: 11850.pdf
Freedom of Information Request Reference: 11838
Date Received: 18/08/2026
Summary:
I therefore request an internal review of this response. In particular, I would ask the reviewer to consider whether the information can be provided in a more proportionate form, for example: • The total number of days the NICU was closed to admissions due to capacity in each year from 2021–2026. • If the exact number cannot be provided without reviewing every individual daily sheet, please provide whatever annual or monthly totals are already available. • If those totals genuinely do not exist, please explain why this information is not routinely collated. • Please also clarify whether there is a central system, electronic record, capacity report, escalation log or other mechanism from which NICU closures can be identified without manually reviewing every daily capacity sheet. • If providing six years of data exceeds the cost limit, please consider narrowing the request to 2025 and 2026 rather than refusing the request in its entirety.
Date of Response: 05/10/2026
View Response: 11838.pdf
Freedom of Information Request Reference: 11787
Date Received: 30/07/2026
Summary:
- Any workforce modelling undertaken since 2023 regarding the oncology, radiology, pathology and cancer nursing workforce required to achieve national cancer waiting time Standards. - Please provide the current policy, protocol or guidance governing the prioritisation or escalation of patients with suspected aggressive or rapidly progressing cancers. - Any audits, reviews or analyses undertaken since 2023 regarding patients whose cancer diagnosis or treatment occurred later than clinically recommended. - Any Serious Adverse Event Reviews, Significant Adverse Event Reviews or equivalent investigations since 2023 where delay in cancer diagnosis or treatment was identified as a contributory factor.
Date of Response: 07/10/2026
View Response: 11787.pdf
Freedom of Information Request Reference: 11756
Date Received: 23/07/2026
Summary:
Please provide the following details regarding your organisation’s lone worker protection arrangements: 1. What lone worker device(s), system(s), or service(s) your Trust currently uses (e.g., dedicated lone worker alarms, smartphone apps, GPS tracking devices, SOS fobs, monitoring platforms, etc.). • Please include the supplier’s name, product name, and type of solution (e.g., hardware device, mobile app, integrated security system). 2. Is the system (if used) monitored by an Alarm Receiving Centre (ARC) or any other system to respond to alarm activations? 3. The number of staff currently registered to use these lone worker devices or systems. 4. How do you monitor percentage of use by your staff? 5. The annual cost of the lone worker system(s) or service(s), including any licensing, subscription, or maintenance fees. 6. Contract details, including: • Contract start date • Contract end date • Whether there are extension options • The procurement route used (e.g., direct award, framework, tender) 7. If applicable, please confirm whether the Trust is considering changing or introducing a lone worker system(s) in the next 12–24 months?
Date of Response: 01/10/2026
View Response: 11756.pdf
Freedom of Information Request Reference: 11726
Date Received: 16/07/2026
Summary:
The total number of staff who have received exit payments, settlement agreements, or redundancy/severance packages in each of the last five financial years (2021-22 to 2025-26). For each payment, please provide: a) The financial year in which the payment was made b) The reason for departure (e.g. compulsory redundancy, settlement agreement, etc) c) The cost of the payment
Date of Response: 07/10/2026
View Response: 11726.pdf
Freedom of Information Request Reference: 11709
Date Received: 13/07/2026
Summary:
1. Aseptic labs and services (pharmacy cleanrooms) 1a. How many aseptic preparation units (pharmacy cleanrooms where sterile medicines are made up) does the trust operate, and what does each mainly prepare (for example chemotherapy, intravenous additives, intravenous feeding, or radiopharmacy, which is radioactive tracers for scans? 1b. For each aseptic unit, in what year was it built or last fully refurbished? A full refurbishment includes replacing the cleanroom air-handling or ventilation. 1c. Does each unit hold a manufacturing “specials” licence from the medicines regulator (the MHRA), or does it operate under the pharmacy exemption (section 10 of the Medicines Act) without a licence? 1d. Has the trust assessed its aseptic units against the current sterile-preparation standard (the updated Annex 1 rules on cleanroom air quality)? If so, do any units fall short of it or need upgrading to comply? 1e. Is any aseptic preparation outsourced to a commercial or external NHS unit? If so, to which provider, and roughly what share of the workload? 1f. Are there approved or planned schemes in the next five years to build, expand, replace or refurbish aseptic units? For each, please give a brief description, an indicative value, and the expected date. 1g. In the last five years, has limited aseptic capacity affected the trust's ability to prepare chemotherapy or other sterile medicines, or led to buying them in from an outside provider? Please describe briefly. 2. Surgical robots and theatre technology 2a. How many surgical robotic systems does the trust currently operate, and of what make and model? 2b. Are there approved or planned schemes to acquire further robotic systems within the next five years? Please give the number and the expected date. 2c. Have any operating theatres been enlarged or upgraded to take robotic or hybrid use in the last five years, or are any such works planned? If so, please describe briefly. 3. Wards and day surgery 3a.. What was the day-case rate for elective surgery (the percentage of elective procedures carried out as day cases) over the most recent twelve months? 3b. Are there approved or planned schemes within the next five years to refurbish or replace surgical wards, or to create a new day-surgery unit? Please describe briefly, with expected dates. 4. Estate agency and continuity 4a. Is RAAC present anywhere in the trust's estate? If yes, is any of it in, or directly adjacent to, operating theatres, endoscopy or decontamination facilities? 4b. In the last five financial years, has the trust used any temporary, mobile or modular clinical facility (theatre, ward, endoscopy, decontamination or diagnostic unit)? For each, please give the facility type, the supplier where recorded, the duration of use, and the total spend. 4c. Does the trust hold a current decant or continuity plan that anticipates moving surgical, endoscopy or decontamination services out of their normal location to allow refurbishment or replacement within the next five years? 5. Capital programme and procurement 5a. Please list the trust's currently approved or planned capital schemes for the next five years that affect operating theatres, endoscopy, decontamination, aseptic services, or surgical wards. For each, please give the scheme name, a brief description, an indicative value, and the expected start and finish dates. 5b. Through which framework or frameworks does the trust usually procure temporary or modular clinical buildings (for example, NHS Supply Chain or Crown Commercial Service)? 5c. In the last five years, has the trust considered or used private finance, third-party investment, or a rental or managed-service arrangement to provide clinical capacity? If so, please describe briefly.
Date of Response: 01/10/2026
View Response: 11709.pdf
Freedom of Information Request Reference: 11684
Date Received: 07/07/2026
Summary:
Where a question asks about future plans, please provide only information the trust currently holds in recorded form, such as an approved business case or an entry in the capital programme. Where no time period is given, the most recent available figure is fine.
Date of Response: 01/10/2026
View Response: 11684.pdf
Freedom of Information Request Reference: 11639
Date Received: 30/06/2026
Summary:
For each calendar year from 2019 to 2026 (most recent): The total number of incidents where a patient fall was reported, broken down by hospital.
Date of Response: 07/10/2026
View Response: 11639.pdf
Freedom of Information Request Reference: 11910
Date Received: 11/09/2026
Summary:
We would be obliged if you could please provide us with information in relation to the waiting times for referrals for spinal cord stimulation under the categories both routine and urgent as at September 2026. By this we mean, if a patient were referred for spinal cord stimulation in September 2026, what would be the average wait time for this patient to receive treatment under these categories.
Date of Response: 30/09/2026
View Response: 11910.pdf
Freedom of Information Request Reference: 11891
Date Received: 07/09/2026
Summary:
For each of financial years 2021/22, 2022/23, 2023/24, 2024/25 and 2025/26 (to date, with the cut-off date stated): 1. How many people whose care you funded were in an inpatient mental health, learning disability or forensic placement outside this Board's own hospitals at year end (or the nearest census you hold), split: a. outwith NHS Scotland; b. in Scotland but not in this Board (another NHS Board or independent provider in Scotland). If (a) is only held as the national census figure, say so and answer (b). 2. Total expenditure (£) on those placements in each year, split (a)/(b) if held. If only a single total is held, provide that and say so.
Date of Response: 29/09/2026
View Response: 11891.pdf
Freedom of Information Request Reference: 11890
Date Received: 07/09/2026
Summary:
As at the most recent date for which figures are held (please state the date), please provide Whole Time Equivalent for: 1. Consultant psychiatrists 2. Other career-grade / SAS psychiatrists, if recorded 3. Psychology services clinical staff (as you report to NES), with applied psychologists separately if held 4. Registered mental health nurses For each of 1–4 please provide: a. funded establishment WTE b. staff in post WTE c. vacancy WTE d. locum or agency WTE covering vacancies, if recorded If you hold a split by adult mental health, CAMHS, and older-age psychiatry/nursing, please provide that split. If not held, board totals are sufficient.
Date of Response: 28/09/2026
View Response: 11890.pdf
Freedom of Information Request Reference: 11885
Date Received: 04/09/2026
Summary:
Does the NHS Lothian Job Evaluation Team consider a "master's level qualification" to be at the same academic level as a "masters degree level qualification" for the purposes of evaluating the Knowledge Training and Experience factor of a nursing job? And if not, why not? And how many NHS Lothian job evaluations, since 2018, will have been affected by any misunderstanding of the meaning of the word "level"? This seems to have been an issue with the NHS Lothian Specialist School Nurse job evaluation in both 2018 and 2025. Please fully explain.
Date of Response: 28/09/2026
View Response: 11885.pdf
Freedom of Information Request Reference: 11879
Date Received: 03/09/2026
Summary:
On how many occasions were children hospitalised for (a) alcohol-related, or (b) drug-related injuries or illnesses in (i) 2016-17, (ii) 2017-18 and (iii) 2018-19, broken down by (A) 0-4 years olds, (B) 5-9 year olds, (C) 10-13 year olds, (D) 14-17 year olds. If an incident was related to both drugs and alcohol, and is therefore included in both categories, please provide details of on how many occasions this occurred, broken down by year and age category. Please include: • both attendances at an emergency department and admissions to hospital • those admitted for observation • cases of accidental consumption
Date of Response: 28/09/2026
View Response: 11879.pdf
Freedom of Information Request Reference: 11870
Date Received: 21/08/2026
Summary:
I would be grateful if you could provide us with a broad indication of the current position, particularly in relation to children in the East Lothian/Lothian area. It would be helpful to understand: * The current approximate waiting time for children awaiting a neurodevelopmental assessment; * Whether waiting times differ between autism, ADHD and wider neurodevelopmental assessments; * Approximately how many children are currently waiting, if this information is available; * Whether there is currently a significant backlog within the service; * Whether families are given any indication of their likely assessment timescale once they are placed on the waiting list; and * What support is available to children and families while they are waiting. We appreciate that individual waiting times will vary depending on the child and the pathway involved. We are therefore not seeking information about any individual patient, but rather a general picture of the current position so that we can give parents accurate information. It would also be helpful if you could clarify whether children waiting specifically for a neurodevelopmental assessment are included within the published CAMHS waiting-time figures, or whether these assessments are recorded separately.
Date of Response: 28/09/2026
View Response: 11870.pdf
Freedom of Information Request Reference: 11863
Date Received: 28/08/2026
Summary:
The difficulty with the response is that my request contained 13 separate numbered points covering several different categories of recorded information. NHS Lothian has largely provided one general answer relating to the difficulty of extracting complication information from individual patient records, followed by reliance on section 12(1) and a section 17 notice. That does not appear to answer the request as made. I accept that questions 2 and 3 may require consideration of clinical records if NHS Lothian has no centrally extractable complication dataset. However, that issue does not explain the absence of answers to separate requests for correspondence, reports, meeting records, policy material, government requests for evidence, advisory-group participation and stakeholder correspondence. In particular, I cannot identify a substantive response to questions 1 and 5 to 13. Question 1 requested correspondence, briefings, reports, presentations, meeting records or advice exchanged with the Scottish Government, Healthcare Improvement Scotland, Public Health Scotland or another body concerning regulation, practitioner restrictions, HIS-registered premises, prescriber or healthcare-professional requirements and procedure classification. Questions 5 to 13 concerned, amongst other things, comparative analyses, information supplied to government, requests received for evidence, advice submitted by NHS Lothian, participation of Board staff in relevant government groups or meetings, assessments of the effect of the legislation upon NHS services, records concerning independent practitioner participation, records concerning the role or standing of named stakeholder organisations, and correspondence with those organisations. None of those categories would ordinarily require NHS Lothian to examine individual patient files. I therefore ask the reviewer to establish what searches were actually undertaken for each of questions 1 and 5 to 13, which departments, offices or record systems were searched, and whether relevant corporate, executive, governance, public health, clinical management, communications and policy records were considered. If NHS Lothian's position is that no recorded information is held for any particular numbered question, please provide a separate section 17 notice for that question so that it is clear what information the Board says it does and does not hold. I would also ask the reviewer to reconsider the application of section 12(1). The response says there would be "significant cost implications", but does not provide an estimated cost, explain how the estimate was calculated, state the number of records which would require examination, or explain which particular numbered parts of my request exceed the statutory cost limit. Please therefore provide the calculation relied upon when applying section 12(1), including the search activities, estimated staff time and costs attributed to them. There is also an apparent inconsistency between relying upon section 12(1), which appears to proceed on the basis that relevant information may exist but would be too costly to retrieve, and then issuing a section 17 notice stating that NHS Lothian does not hold "the requested information". Those are materially different positions. I would be grateful if the review could distinguish clearly between: 1. information which NHS Lothian holds but considers too costly to locate or extract under section 12(1); 2. information which NHS Lothian does not hold for the purposes of section 17; and 3. information which can be provided without exceeding the cost limit. I would also ask the reviewer to consider whether NHS Lothian complied with its duty to provide reasonable advice and assistance. If obtaining the full figures requested in questions 2 and 3 would exceed the cost limit, please identify whether any existing extracts, audits, incident reports, departmental statistics, reports, summaries or narrower recorded information can be provided without requiring a manual review of every patient record. Finally, the response from Plastic Surgery states that the department does not keep a note of complications from patients who had procedures carried out by a "non-medical practitioner". My request used a specific definition of "independent aesthetic practitioner". Please confirm whether searches were conducted using the definition in my request rather than relying upon a different or narrower category. I am not asking NHS Lothian to create new information. I am asking it to reconsider whether existing recorded information falling within each separate part of the request has been properly searched for and whether the exemptions and information-not-held notice have been applied to the appropriate parts of the request. Please conduct a fresh review and provide a point-by-point outcome for questions 1 to 13.
Date of Response: 29/09/2026
View Response: 11863.pdf
Freedom of Information Request Reference: 11859
Date Received: 28/08/2026
Summary:
1. The answer to my previous question 1 refers to pausing new referrals "until there was surgical throughput and capacity”. Does that mean that that throughput and capacity still doesn’t exist? 2. What additional resources, human and otherwise, are needed to create sufficient surgical throughput and capacity (assuming that “no” is the answer to my first question)? 3. Are you saying that the number of consultants makes no difference to the treatment that can be offered, and will not affect the decision to reopen the pathway? 4. How many other WTE doctors are there? 5. How big is the “available budget”? 6. When was the available budget last decided? 7. Who made that decision? 8. How much bigger would the available budget have to be before the pathway could be reopened?
Date of Response: 28/09/2026
View Response: 11859.pdf
Freedom of Information Request Reference: 11855
Date Received: 24/08/2026
Summary:
Q1. Does your health board currently provide transport for patients to and from in-centre dialysis? If yes: a. Please list each mode of transport you provide. b. Please list which modes of transport in 1a are needs assessed. (Definition of needs assessed = a patient’s medical, physical, and social circumstances are assessed to determine their eligibility for transport to and from in-centre dialysis) c. Please provide a link to, or outline of, the needs assessment criteria and policy for each mode of transport identified in 1b. d. Please list which modes of transport in 1a are means tested? (Definition of means tested = a patient qualifies for transport to and from in-centre dialysis due to financial hardship or low income and may be in receipt of government benefits) e. Please provide a link to, or outline of, the means tested criteria and policy for each mode of transport identified in 1d. f. Are any of the modes of transport listed in 1a restricted to certain days and/or to certain times of day that a patient can use them travel to and from in-centre dialysis? Travel by public transport Q2. Does your health board currently reimburse kidney patients who travel by public transport to and from in-centre dialysis? If YES: a. Are patients reimbursed in full for their travel by public transport? If NO: Please outline the rates utilised to reimburse patients who use public transport. b. Are all patients who travel by public transport to and from in-centre dialysis reimbursed for their travel, or is this means tested? (Definition of means tested = a patient qualifies for transport to and from in-centre dialysis due to financial hardship or low income and may be in receipt of government benefits) If means tested: Please provide a link to, or outline of, the means tested criteria and policy for travel by public transport to and from in-centre dialysis. Travel by private taxi Q3. Does your health board currently reimburse kidney patients who travel by private taxi to and from in-centre dialysis? (Definition of private taxi = a taxi organised by the patient and not agreed and arranged by the hospital/ dialysis unit) If YES: a. Are patients reimbursed in full for their travel by private taxi? If NO: Please outline the rates utilised to reimburse patients who use private taxis. b. Are all patients who travel by private taxi to and from in-centre dialysis reimbursed for their travel, or is this means tested? (Definition of means tested = a patient qualifies for transport to and from in-centre dialysis due to financial hardship or low income and may be in receipt of government benefits) If means tested: Please provide a link to, or outline of, the means tested criteria and policy for travel by private taxi and from in-centre dialysis. Travel by private car Q4. Does your health board currently reimburse the cost of fuel for kidney patients who travel by private car to and from in-centre dialysis? (Definition of private car = travel in their own vehicle, or a family member’s or friend’s car to and from incentre dialysis) If YES: a. Are patients reimbursed in full for their fuel costs when they travel by private car to and from in-centre dialysis? If NO: Please outline the rates at which their fuel costs are reimbursed. b. Are all patients who travel by private car to and from in-centre dialysis reimbursed for their fuel costs, or is this means tested? (Definition of means tested = a patient qualifies for transport to and from in-centre dialysis due to financial hardship or low income and may be in receipt of government benefits) If means tested: Please provide a link to, or outline of, the means tested criteria and policy for travel by private car to and from in-centre dialysis. Other comments Q5. Do you have any other comments about the dialysis transport services your health board provides? - for e.g. whether there is a review of renal transport services planned soon in your health board or of this is ongoing, or if you have specific issues and concerns about the service.
Date of Response: 29/09/2026
View Response: 11855.pdf
Freedom of Information Request Reference: 11832
Date Received: 17/08/2026
Summary:
I'd like to know the bed availability at the Royal Edinburgh hospital for mental health and St John's hospital in Livingston during 21st October 2024 until 21st November 2024.
Date of Response: 28/09/2026
View Response: 11832.pdf
Freedom of Information Request Reference: 11733
Date Received: 17/07/2026
Summary:
1. In the last 6 months (November 2025 to April 2026), how many adult patients were treated by the dermatology department, excluding patients referred for cancer/suspected cancer? 2. Do you run a specific clinic for patients with atopic dermatitis? 3. In the last 6 months (November 2025 to April 2026), how many adult patients with atopic dermatitis were treated by the dermatology department? 4. In the last 6 months (November 2025 to April 2026), how many adult patients with atopic dermatitis were treated with the following products: a. Immunosuppressants (Azathioprine, Ciclosporin, Methotrexate, Mycophenolate mofetil, Pimecrolimus, or Tacrolimus) b. Abrocitinib c. Baricitinib d. Dupilumab e. Lebrikizumab f. Tralokinumab g. Upadacitinib h. Nemolizumab i. Delgocitinib 5. In the last 6 months (November 2025 to April 2026), how many adult patients with atopic dermatitis were started on the following products: a. Immunosuppressants (Azathioprine, Ciclosporin, Methotrexate, Mycophenolate mofetil, Pimecrolimus, or Tacrolimus) b. Abrocitinib c. Baricitinib d. Dupilumab e. Lebrikizumab f. Tralokinumab g. Upadacitinib h. Nemolizumab i. Delgocitinib
Date of Response: 30/09/2026
View Response: 11733.pdf
Freedom of Information Request Reference: 11661
Date Received: 02/07/2026
Summary:
1. A complete list of CAMHS vacancies currently open in NHS Lothian. Please provide for each vacancy the name of the position and how many days the vacancy has been open for. Please note that websites do not provide all of that info, so I would appreciate the board providing it. 2. The total number of CAMHS positions in NHS Lothian 3. The total number of those CAMHS positions that are currently filled/occupied. Please provide the number (please also provide it as a percentage), that are currently occupied and the number (please also provide it as a percentage) that aren’t occupied.
Date of Response: 28/09/2026
View Response: 11661.pdf
Freedom of Information Request Reference: 11964
Date Received: 24/09/2026
Summary:
Request in relation to personal information.
Date of Response: 24/09/2026
View Response: 11964.pdf
Freedom of Information Request Reference: 11954
Date Received: 22/09/2026
Summary:
Long term care is provided to clients on an ongoing basis and varies from high intensity provision such as nursing care, to lower intensity support in the community such as the provision of direct payments to arrange regular home care visits. Please provide answers on the attached and accompanying spreadsheet. 1. Please supply the name, email address and telephone number of the commissioner with responsibility for placements in supported living 2. Please provide the total number of adults (aged 18-64) with a primary support need of learning disabilities (LD) or Autism Spectrum Disorder (ASD) funded by the ICB/Health Board and receiving long-term care in supported living settings. Please provide data for the financial years 2021/22, 2022/23, 2023/24, 2024/25, 2025/26 and where possible projected figures for 2026/27 a. How many are placed in area (i.e. within the ICB/Health Board boundary)? b. How many are placed out of area (i.e. outside the ICB/Health Board boundary)? 3. Please provide a list of providers of supported living services used by the ICB/Health Board to place adults (aged 18-64) with a primary support need of LD or ASD receiving long-term care. To clarify, this does not include sole providers of accommodation, such as Housing Associations; only care providers registered to deliver personal care, and is only those providers registered as a care agency with the inspectorate. Please provide data for the latest month (if available); if not the last financial year 2025/26 – please state which timescale has been used for the data provided. a. Please provide, for each provider, the number of adults aged 18-64 with LD or ASD funded by the ICB/Health Board in long-term supported living placements b. Please provide total expenditure with each provider related to long-term placements in supported living for adults aged 18-64 with LD or ASD 4. Please provide the (a) highest, (b) lowest and (c) average weekly fee the ICB/Health Board pays to providers of long-term care in supported living settings for adults (aged 18-64) with LD or ASD. Please provide data for the latest month (if available); if not, the last financial year 2025/26 5. Please provide the number of adults (aged 18-64) with primary support need of LD or ASD in supported living with fees per week of: a. Less than £1,500 b. £1,500 to £2,999 c. £3,000 to £4,999 d. £5,000 to £6,999 e. £7,000 and more 6. Does the ICB/Health Board consider there is sufficient local supported living care provision to meet the needs of aged 18-64 with learning disabilities and/or autism and which providers does the ICB/Health Board mainly use for these placements? What are occupancy levels locally?
Date of Response: 25/09/2026
View Response: 11954.pdf
Freedom of Information Request Reference: 11943
Date Received: 21/09/2026
Summary:
Request in relation to medical records.
Date of Response: 21/09/2026
View Response: 11943.pdf
Freedom of Information Request Reference: 11908
Date Received: 10/09/2026
Summary:
NHS Lothian's role in overseeing the handback process and associated remedial works, you may be best placed to provide advice or direct me to the appropriate colleagues. In particular, I would be grateful for any information on: • Who is responsible for overseeing the handback process and associated remedial works. • What assurances are in place to ensure the required works are completed before handback. • Any background on why significant remedial works have been identified. • Any information that can be shared regarding governance, monitoring arrangements, or reported funding issues.
Date of Response: 24/09/2026
View Response: 11908.pdf
Freedom of Information Request Reference: 11907
Date Received: 10/09/2026
Summary:
I was wondering if it would be possible to obtain a list of email addresses for GP practices?
Date of Response: 25/09/2026
View Response: 11907.pdf
Freedom of Information Request Reference: 11898
Date Received: 08/09/2026
Summary:
I am writing to request information regarding active General Practices (GP practices) operating within your NHS Health Board region. Specifically, please provide a list containing the following details for each practice: - Practice Code - Practice Name - Practice Address and Postcode - Generic Practice Email Address (e.g., administrative, reception, or practice-level @nhs.scot / @nhs.net address) - Practice Manager Name - Practice Manager Email Address
Date of Response: 23/09/2026
View Response: 11898.pdf
Freedom of Information Request Reference: 11896
Date Received: 07/09/2026
Summary:
How many new patients were treated for any condition by the Trust's Dermatology and Rheumatology Department in the latest 3-month period of April, May and June 2026 (or the latest 3 months available) with the treatments I have provided below? Please can you define a "new patient" as a patient who is receiving any of the treatments listed below for the first time. If a patient received any of the below treatments in 2024 or previous years, they can be classed as a new patient for this period. Abatacept [Orencia] Adalimumab [Humira] Adalimumab [All Biosimilars] Apremilast [Generic] Apremilast [Otezla] Baricitinib [Olumiant] Bimekizumab [Bimzelx] Brodalumab [Kyntheum] Certolizumab [Cimzia] Deucravacitinib [Sotyktu] Dimethyl Fumarate [Skilarence] Etanercept [Enbrel] Etanercept [All Biosimilars] Filgotinib [Jyseleca] Golimumab [Simponi] Golimumab [All Biosimilars] Guselkumab [Tremfya] Infliximab [Remicade] Infliximab [All Biosimilars] Ixekizumab [Taltz] Risankizumab [Skyrizi] Rituximab [MabThera] Rituximab [Biosimilars] Sarilumab [Kevzara] Secukinumab [Cosentyx] Spesolimab [Spevigo] Tildrakizumab [illumetri] Tocilizumab [RoActemra] Tocilizumab [Biosimilars] Tofacitinib [Xeljanz] Upadacitinib [Rinvoq] Ustekinumab [Stelara] Ustekinumab [All Biosimilars]
Date of Response: 25/09/2026
View Response: 11896.pdf
Freedom of Information Request Reference: 11888
Date Received: 07/09/2026
Summary:
Please provide the following information, as of 7th September 2026 (or most recent): •For each Walk-in GP Clinic in your health board: 1) Has the Walk-in Clinic experienced an unexpected closure and, if so, on what dates? 2) If for part of a day, over what time period was the unexpected closure? 3) For each calendar month since the Walk-in Clinic was opened, what has been the total number of patient attendances resulting in a patient receiving a medical assessment by a) a GP or b) a nurse? 4) For each calendar month since the Walk-in Clinic was opened, what has been the highest number of patient attendances in a single day that resulted in a patient receiving a medical assessment by a) a GP or b) a nurse? 5) For each calendar month since the Walk-in Clinic was opened, what has been the lowest number of patient attendances in a single day that resulted in a patient receiving a medical assessment by a) a GP or b) a nurse? •For each unexpected closure of a Walk-in Clinic, what was the reason for the clinic to be closed?
Date of Response: 25/09/2026
View Response: 11888.pdf
Freedom of Information Request Reference: 11881
Date Received: 03/09/2026
Summary:
Request in relation to workforce systems.
Date of Response: 25/09/2026
View Response: 11881.pdf
Freedom of Information Request Reference: 11880
Date Received: 03/09/2026
Summary:
Could you please provide the numbers of patients treated by the rheumatology department (for any condition) in the last 3 months with the following drugs: • Abatacept [Orencia] • Adalimumab [Humira] • Adalimumab Biosimilars • Apremilast [Otezla] • Apremilast [Generic] • Baricitinib [Olumiant] • Bimekizumab [Bimzelx] • Certolizumab [Cimzia] • Etanercept [Enbrel] • Etanercept Biosimilars • Filgotinib [Jyseleca] • Golimumab [Simponi] • Golimumab Biosimilar • Guselkumab [Tremfya] • Infliximab [Remicade] • Infliximab Biosimilars • Ixekizumab [Taltz] • Risankizumab [Skyrizi] • Rituximab [MabThera] • Rituximab Biosimilars • Sarilumab [Kevzara] • Secukinumab [Cosentyx] • Tocilizumab [Ro Actemra] • Tocilizumab Biosimilars • Tofacitinib [Xeljanz] • Upadacitinib [Rinvoq] • Ustekinumab [Stelara] • Ustekinumab Biosimilar
Date of Response: 24/09/2026
View Response: 11880.pdf
Freedom of Information Request Reference: 11877
Date Received: 03/09/2026
Summary:
Question One: How many patients has your trust treated in the past six months (for any disease) with the following drugs: Aubagio (teriflunomide) Avonex (interferon beta-1a) Betaferon (interferon beta-1b) Brabio (glatiramer acetate) Copaxone (glatiramer acetate) Extavia (beta interferon-1b) Gilenya (fingolimod) Kesimpta (ofatumumab) Lemtrada (alemtuzumab) Mavenclad (cladribine) Mayzent (siponimod) Ocrevus (ocrelizumab) Plegridy (peginterferon beta-1a) Ponvory (ponesimod) Rebif (beta interferon-1a) Tecfidera (dimethyl fumarate) Tysabri (natalizumab) Tysabri (natalizumab) Pre-filled syringes only Vumerity (diroximel fumarate) Zeposia (ozanimod) Fingolimod generic Tyruko (Natalizumab Biosimilar) Briumvi (ublituximab) Dimethyl fumarate generic Teriflunomide generic Question Two: How many patients has your trust treated with Rituximab for MS (Multiple Sclerosis) in the past six months? Question Three: How many patients within your trust have a diagnosis of MS (Multiple Sclerosis)?
Date of Response: 24/09/2026
View Response: 11877.pdf
Freedom of Information Request Reference: 11874
Date Received: 01/09/2026
Summary:
I'd like copies of the minutes of the meetings held to date ( August 2026) as referenced here - (item 4 progress update).
Date of Response: 24/09/2026
View Response: 11874.pdf
Freedom of Information Request Reference: 11873
Date Received: 01/09/2026
Summary:
How many patients were treated in the last 3 months by the Dermatology department (for any medical condition) with the following biologic drugs: • Adalimumab - Humira • Adalimumab Biosimilar • Apremilast - Otezla • Apremilast generic • Bimekizumab • Brodalumab • Certolizumab • Deucravacitinib • Dimethyl fumarate • Etanercept - Enbrel • Etanercept Biosimilar • Guselkumab • Infliximab - Remicade • Infliximab Biosimilar • Ixekizumab • Risankizumab • Secukinumab • Tildrakizumab • Ustekinumab - Stelara • Ustekinumab Biosimilar • Omalizumab • Spesolimab
Date of Response: 24/09/2026
View Response: 11873.pdf
Freedom of Information Request Reference: 11872
Date Received: 01/09/2026
Summary:
Now that the supplementary agreement has been agreed between NHS Lothian and Consort in relation to the RIE, please can you tell me how much money, to date, Consort has received to make up for the fact the Scottish government has mandated that parking should be free of charge at the RIE.
Date of Response: 18/09/2026
View Response: 11872.pdf
Carer Positive Icon
Awards Aware Icon
We are a Living wage Employer Icon
Duke of Edinburgh's Award Logo
Young Person's Guaranteed Employer Logo
Scottish Top Employers Logo
Disability Confident Employer Logo
 
CONTACT NHS LOTHIAN
Lothian NHS Board
Waverley Court
4 East Market Street
Edinburgh
EH8 8BG

Main Switchboard: 0131 242 1000
YOUR RIGHTS
OUR VALUES INTO ACTION
Around 3,000 colleagues across NHS Lothian have developed Our Values, a set of common values and ways of working - to the benefit of everyone working in the organisation and, most importantly - to the benefit of our patients.
WORKING WITH NHS LOTHIAN
MEDIA ENQUIRIES
STAY CONNECTED TO NHS LOTHIAN
Facebook
Twitter
YouTube
Vimeo
Instagram
PARTNERS
NHS Lothian Charity Logo
Scottish Registered Charity No: SC007342
The official charity of NHS Lothian.
From the everyday to the transformational, we support NHS Lothian to excel for all the communities it serves: patients, families, carers and staff.
Making healthcare better, together.
Find out more about NHS Lothian Charity
Donate